Juergensen P H, Rizvi H, Caride V J, Kliger A S, Finkelstein F O
New Haven CAPD, Renal Research Institute, Department of Medicine, Saint Raphael Hospital and Yale University School of Medicine, New Haven, Connecticut 06511, USA.
Kidney Int. 1999 Mar;55(3):1111-9. doi: 10.1046/j.1523-1755.1999.0550031111.x.
A variety of factors can adversely impact chronic peritoneal dialysis (CPD) as an effective renal replacement therapy for patients with end-stage renal disease. These factors include peritonitis, poor clearances, loss of ultrafiltration, and a variety of anatomic problems, such as hernias, peritoneal fluid leaks, loculations, and catheter-related problems caused by omental blockage. This study reviews our experience with peritoneal scintigraphy for the evaluation of some of these difficulties.
From 1991 to 1996, 50 peritoneal scintigraphy scans were obtained in 48 CPD patients. Indications for scintigraphy were evaluated, and the patients were placed into four groups: group I, abdominal wall swelling; group II, inguinal or genital swelling; group III, pleural fluid; and group IV, poor drainage and/or poor ultrafiltration. A peritoneal scintigraphy protocol was established and the radiotracer isotope that was used was 2.0 mCi of 99mtechnetium sulfur colloid placed in two liters of 2.5% dextrose peritoneal dialysis solution.
Ten scans were obtained to study abdominal wall swelling, with seven scans demonstrating leaks; six of these episodes improved with low-volume exchanges. Twenty scans were obtained to evaluate inguinal or genital swelling, and 10 of these had scintigraphic evidence for an inguinal hernia leak (9 of these were surgically corrected). One of four scans obtained to evaluate a pleural fluid collection demonstrated a peritoneal-pleural leak that corrected with a temporary discontinuation of CPD. Sixteen scans were obtained to assess poor drainage and/or ultrafiltration. Five of these scans demonstrated peritoneal location, and all of these patients required transfer to hemodialysis. The other 11 scans were normal; four patients underwent omentectomies, allowing three patients to continue with CPD.
Peritoneal scintigraphy is useful in the evaluation and assessment of CPD patients who develop anatomical problems (such as anterior abdominal, pleural-peritoneal, inguinal, and genital leaks) and problems with ultrafiltration and/or drainage.
多种因素会对慢性腹膜透析(CPD)产生不利影响,而CPD是终末期肾病患者有效的肾脏替代治疗方法。这些因素包括腹膜炎、清除率不佳、超滤功能丧失以及各种解剖学问题,如疝气、腹膜液渗漏、肠粘连和由网膜阻塞引起的导管相关问题。本研究回顾了我们使用腹膜闪烁显像评估其中一些难题的经验。
1991年至1996年,对48例CPD患者进行了50次腹膜闪烁显像扫描。对闪烁显像的适应证进行了评估,并将患者分为四组:第一组,腹壁肿胀;第二组,腹股沟或生殖器肿胀;第三组,胸腔积液;第四组,引流不畅和/或超滤功能不佳。制定了腹膜闪烁显像方案,使用的放射性示踪剂同位素为2.0毫居里的99m锝硫胶体,置于两升2.5%葡萄糖腹膜透析液中。
进行了10次扫描以研究腹壁肿胀,其中7次扫描显示有渗漏;其中6次通过小容量交换得到改善。进行了20次扫描以评估腹股沟或生殖器肿胀,其中10次闪烁显像有腹股沟疝渗漏的证据(其中9例接受了手术矫正)。在评估胸腔积液的4次扫描中,有1次显示腹膜-胸膜渗漏,通过暂时停止CPD得以纠正。进行了16次扫描以评估引流不畅和/或超滤功能不佳。其中5次扫描显示有腹膜定位,所有这些患者都需要转为血液透析。其他11次扫描正常;4例患者接受了网膜切除术,使3例患者能够继续进行CPD。
腹膜闪烁显像有助于评估和评估出现解剖学问题(如前腹壁、胸膜-腹膜、腹股沟和生殖器渗漏)以及超滤和/或引流问题的CPD患者。